Literature DB >> 26339078

Causes of Death in Hospitalized HIV Patients in the Early Anti-Retroviral Therapy Era.

M Lartey1, A Asante-Quashie2, A Essel3, E Kenu4, V Ganu4, A Neequaye1.   

Abstract

OBJECTIVE: To establish the cause(s) of death among persons with HIV and AIDS admitted to the Fevers Unit of the Korle-Bu Teaching Hospital (KBTH) in 2007 and to determine whether they were AIDS-related in the era of availability of HAART.
METHOD: Retrospective chart review of all deaths that occurred in the year 2007 among inpatients with HIV infection. Cause of Death (COD) was established with post mortem diagnosis, where not available ICD-10 was reviewed independently by two physicians experienced in HIV medicine and a consensus reached as to the most likely COD.
RESULTS: In the year under review, 215 (97%) of the 221 adult deaths studied were caused by AIDS and HIV-associated illnesses. Of these, 123 (55.7%) were due to an AIDS-defining illness as described in CDC Category 3 or WHO stage 4. Infections accounted for most of the deaths 158 (71.5%), many of them opportunistic 82 (51.8%). Tuberculosis was the commonest COD. Clinical diagnosis of TB was accurate in 54% of deaths, but was not validated by autopsy in 36% of deaths. There were few deaths (14.5%) in patients on HAART.
CONCLUSION: In a developing country like Ghana where HAART was still not fully accessible, AIDS-related events remained the major causes of death in persons living with HIV. Total scale-up of the ART programme with continuous availability of antiretrovirals is therefore imperative to reduce deaths from AIDS and HIV associated illnesses. There is need for interventions for early diagnosis as well as reduction in late presentation and also better diagnostic tools for tuberculosis.

Entities:  

Keywords:  AIDS; Cause of death; Ghana; HAART; HIV; Tuberculosis

Mesh:

Year:  2015        PMID: 26339078      PMCID: PMC4549815          DOI: 10.4314/gmj.v49i1.2

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  15 in total

1.  Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Authors:  Nancy F Crum; Robert H Riffenburgh; Scott Wegner; Brian K Agan; Sybil A Tasker; Katherine M Spooner; Adam W Armstrong; Susan Fraser; Mark R Wallace
Journal:  J Acquir Immune Defic Syndr       Date:  2006-02-01       Impact factor: 3.731

2.  AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment.

Authors:  Kathleen Falster; Jun Yong Choi; Basil Donovan; Chris Duncombe; Brian Mulhall; David Sowden; Jialun Zhou; Matthew G Law
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

3.  Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study.

Authors:  R Weber; M Ruppik; M Rickenbach; A Spoerri; H Furrer; M Battegay; M Cavassini; A Calmy; E Bernasconi; P Schmid; M Flepp; J Kowalska; B Ledergerber
Journal:  HIV Med       Date:  2012-09-24       Impact factor: 3.180

4.  Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians.

Authors:  Patricia Aladi Agaba; Eunice Digin; Rahila Makai; Labake Apena; Oche O Agbaji; John A Idoko; Rob Murphy; Phyllis Kanki
Journal:  J Infect Dev Ctries       Date:  2011-05-28       Impact factor: 0.968

5.  Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Authors:  Jean-François Etard; Ibrahima Ndiaye; Marion Thierry-Mieg; Ndèye Fatou Ngom Guèye; Pape Mandoumbé Guèye; Isabelle Lanièce; Allé Baba Dieng; Assane Diouf; Christian Laurent; Souleymane Mboup; Papa Salif Sow; Eric Delaporte
Journal:  AIDS       Date:  2006-05-12       Impact factor: 4.177

6.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

7.  Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire.

Authors:  Gaston Djomand; Thierry Roels; Tedd Ellerbrock; Debra Hanson; Fabien Diomande; Bondo Monga; Chantal Maurice; John Nkengasong; Regina Konan-Koko; Auguste Kadio; Stefan Wiktor; Eve Lackritz; Joseph Saba; Terence Chorba
Journal:  AIDS       Date:  2003-07       Impact factor: 4.177

8.  Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999.

Authors:  F Bonnet; P Morlat; G Chêne; P Mercié; D Neau; I Chossat; M Decoin; F Djossou; J Beylot; F Dabis
Journal:  HIV Med       Date:  2002-07       Impact factor: 3.180

9.  Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Authors:  C-H Yang; Y-F Huang; C-F Hsiao; Y-L Yeh; H-R Liou; C-C Hung; S-Y Yang
Journal:  HIV Med       Date:  2008-06-28       Impact factor: 3.180

10.  Trends of mortality and cause of death among HIV-infected patients in Korea, 1990-2011.

Authors:  Sun Hee Lee; Kye-Hyung Kim; Seung Geun Lee; Dong Hwan Chen; Dong Sik Jung; Chi Sook Moon; Ji Young Park; Joo Seop Chung; Ihm Soo Kwak; Goon Jae Cho
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

View more
  6 in total

1.  Cryptococcal and Histoplasma Antigen Screening Among People With Human Immunodeficiency Virus in Ghana and Comparative Analysis of OIDx Histoplasma Lateral Flow Assay and IMMY Histoplasma Enzyme Immunoassay.

Authors:  Bright K Ocansey; Benjamin Otoo; Isabella Asamoah; Vincent Ganu; Kofi P Berko; Oluwakemi Oladele; Emmanuella A Amankwa; Bismark Opoku-Asare; Martin Agyei; Lawrence George; Fleischer C N Kotey; Chris Kosmidis; Peter Puplampu; Japheth A Opintan; David W Denning
Journal:  Open Forum Infect Dis       Date:  2022-06-03       Impact factor: 4.423

2.  High rates of cerebral toxoplasmosis in HIV patients presenting with meningitis in Accra, Ghana.

Authors:  Japheth A Opintan; Benedict K Awadzi; Isaac J K Biney; Vincent Ganu; Richard Doe; Ernest Kenu; Rita F Adu; Mary M Osei; Amos Akumwena; Michael E Grigg; Gary A Fahle; Mercy J Newman; Peter R Williamson; Margaret Lartey
Journal:  Trans R Soc Trop Med Hyg       Date:  2017-10-01       Impact factor: 2.184

3.  Causes of death and factors associated with early mortality of HIV-infected adults admitted to Korle-Bu Teaching Hospital.

Authors:  Adriana Saavedra; Nia Campinha-Bacote; Maurice Hajjar; Ernest Kenu; Fizza Syeda Gillani; Adjoa Obo-Akwa; Margaret Lartey; Awewura Kwara
Journal:  Pan Afr Med J       Date:  2017-05-18

4.  Immediate Antiretroviral Therapy Decreases Mortality Among Patients With High CD4 Counts in China: A Nationwide, Retrospective Cohort Study.

Authors:  Yan Zhao; Zunyou Wu; Jennifer M McGoogan; Cynthia X Shi; Aihua Li; Zhihui Dou; Ye Ma; Qianqian Qin; Ron Brookmeyer; Roger Detels; Julio S G Montaner
Journal:  Clin Infect Dis       Date:  2018-02-10       Impact factor: 9.079

5.  Clinico-mycological analysis and antifungal resistance pattern in human immunodeficiency virus-associated candidiasis: An Indian perspective.

Authors:  Ravinder Kaur; Bhanu Mehra; Megh Singh Dhakad; Ritu Goyal; Preena Bhalla; Richa Dewan
Journal:  Indian J Sex Transm Dis AIDS       Date:  2018 Jul-Dec

6.  Incidence of Mortality and Its Predictors Among HIV Positive Adults on Antiretroviral Therapy in University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

Authors:  Achamyeleh Birhanu Teshale; Adino Tesfahun Tsegaye; Haileab Fekadu Wolde
Journal:  HIV AIDS (Auckl)       Date:  2021-01-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.